Revenue: As of FY2025 Q2, the actual value is USD 0.EPS: As of FY2025 Q2, the actual value is USD -0.1.EBIT: As of FY2025 Q2, the actual value is USD -98.91 K.<h3>Segment Revenue</h3><ul><li>The company has not generated any operating revenues as of June 30, 2025, and will not generate any until after the completion of its initial Business Combination.</li></ul><h3>Operational Metrics</h3><ul><li>Net Income: For the three months ended June 30, 2025, the net loss was - $542,059, compared to a net income of $145,656 for the same period in 2024. For the six months ended June 30, 2025, the net loss was - $616,178, compared to a net loss of - $321,060 for the same period in 2024.</li><li>Operating Costs: Formation and operating costs were $72,946 for the three months ended June 30, 2025, compared to $70,749 for the same period in 2024. For the six months ended June 30, 2025, the operating costs were $148,774, compared to $158,282 for the same period in 2024.</li><li>Change in Fair Value of Warrant Liability: For the three months ended June 30, 2025, the change in fair value of warrant liability was - $495,079, compared to $140,200 for the same period in 2024. For the six months ended June 30, 2025, the change in fair value of warrant liability was - $534,510, compared to - $324,211 for the same period in 2024.</li></ul><h3>Cash Flow</h3><ul><li>Operating Cash Flow: Net cash used in operating activities was - $148,081 for the six months ended June 30, 2025, compared to - $204,261 for the same period in 2024.</li><li>Free Cash Flow: Not explicitly mentioned, but the company had $212 in cash on hand as of June 30, 2025, unchanged from December 31, 2024.</li></ul><h3>Unique Metrics</h3><ul><li>Trust Account Balance: The balance in the Trust Account decreased significantly due to redemptions, from $225,411,726 as of March 31, 2023, to $1,865,847 as of June 30, 2025.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company is focused on completing its initial Business Combination. The company has until October 14, 2025, to consummate a business combination, with the possibility of monthly extensions by depositing $15,251.10 per month into the Trust Account.</li><li>Non-Core Business: The company has entered into a Business Combination Agreement with Leading Group Limited, a provider of insurance products in the People’s Republic of China. The agreement includes the cancellation of the company’s ordinary shares in exchange for Holdco Class A shares and the issuance of Holdco Class A Ordinary Shares to LEADING equity holders.</li><li>Priority: The company is prioritizing the completion of the Business Combination with Leading Group Limited and maintaining sufficient liquidity to operate until the Business Combination is completed.</li></ul>

HEALTHCARE AI ACQUISITION CORP UNIT 1 CL A COM & 1/2 WT EXP(07/12/2026) | 10-Q: FY2025 Q2 Revenue: USD 0